Sam Letcher has a diverse work experience spanning different industries. In 2016 and 2017, they worked as an intern at Cazenove Capital. In 2018, Sam joined Hanson Wade as a Program Director, where they organized conferences and events focused on cell and viral immunotherapies. They were later promoted to Senior Program Director and received the company's 'Rising Star' award in 2019. In 2020, Sam transitioned to Pathios Therapeutics, initially working as an Associate and then as a Project Support, managing projects related to drug discovery and macrophage research. They were later promoted to a Project Manager role, where they oversaw CMC, Toxicology, DMPK, and Chemistry projects.
Sam Letcher attended Lancaster Royal Grammar School from 2007 to 2014. However, no specific degree or field of study was mentioned during this period. From 2014 to 2018, Sam pursued a degree at UCL, where they obtained an MSci in Chemistry.
September, 2022 - present
July, 2021
June, 2020